Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 1,458 Jan 1 – Oct 23, 2026
- Disclosed funding
- $62.7B 1189 disclosed amounts
- Median round
- $6.9M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| P PanoraCompany profile Develops AI software for insurance brokers to automate administrative and operational workflows Develops AI software for insurance brokers to automate administrative and operational workflows | $5M | Seed | Fintech | France | Investors | |
| W Digital wardrobe platform for users to manage, style and resell clothing | $7M | Seed | Ecommerce | United Kingdom | Investors | |
| PF Develops commercial fusion power plants based on stellarator concept | €411M | Growth | Climate tech | Germany | Investors | |
| AI ARC IntelligenceCompany profile ARC Intelligence connects enterprise systems to give finance and operating teams answers, checks and reports from their existing business data. ARC Intelligence connects enterprise systems to give finance and operating teams answers, checks and reports from their existing business data. | €4M | Seed | Fintech | Germany | Investors | |
| LA Luffy AI develops neuroplastic AI software for industrial control systems. | £8.1M | Series A | Robotics | United Kingdom | Investors | |
| B BIZAYCompany profile Provides digital platform for customized marketing materials, packaging, and promotional products Provides digital platform for customized marketing materials, packaging, and promotional products | $55M | Series DSeries C+ | Ecommerce | Portugal | Investors | |
| HT Healome TherapeuticsCompany profile Develops proprietary eye-drop matrix technology for ocular surface diseases Develops proprietary eye-drop matrix technology for ocular surface diseases | £2M | Seed | Biotech | United Kingdom | Investors | |
| CT Cyllene TherapeuticsCompany profile Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases Develops DNA medicines for severe neurogenic bladder conditions and other neurological diseases | €33M | Series CSeries C+ | Biotech | France | Investors | |
| P Develops advanced materials for industrial separation and water treatment | €2.4M | Pre-SeedPre-seed | Climate tech | Germany | Investors | |
| C CurifyLabsCompany profile CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. CurifyLabs develops software and GMP-manufactured excipients for preparing personalized medicines. | $14M | Series A | Healthtech | Finland | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1High-Tech Gründerfonds
Rabot Energy, TODAY, Finches
39rounds4led - 2Antler
Jenz, Affinity Labs, CodeWall
26rounds0led - 3Y Combinator (YC)
HyLight, Sensible Biotechnologies, Revnu
22rounds1led - 4General Catalyst
Legora, Complir, Integral
21rounds1led - 5Index Ventures
Opply, Duvo, Spiko
21rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.